Multiple gene aberrations and breast cancer: Lessons from super-responders

The presence of multiple molecular aberrations in patients with breast cancer may correlate with worse outcomes. We performed in-depth molecular analysis of patients with estrogen receptor-positive, HER2- negative, hormone therapy-refractory breast cancer, who achieved partial or complete responses when treated with anastrozole and everolimus